44 studies found for:    HIV AND "treatment naive" | Open Studies | HIV
Show Display Options
RSS Create an RSS feed from your search for:
HIV AND "treatment naive" | Open Studies | HIV
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents
Conditions: Acquired Immune Deficiency Syndrome (AIDS);   HIV Infections
Intervention: Drug: E/C/F/TAF
2 Unknown  Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: Raltegravir;   Drug: Atazanavir/Ritonavir
3 Recruiting Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Condition: HIV Infection
Interventions: Drug: Reformulated Raltegravir;   Drug: Raltegravir;   Drug: TRUVADA™;   Drug: Placebo to Reformulated Raltegravir;   Drug: Placebo to Raltegravir
4 Recruiting Compare the Efficacy and Safety of Raltegravir Versus Efavirenz Combination Therapy in Treatment-naïve HIV-1 Patients
Condition: HIV-1 Infection
Interventions: Drug: Raltegravir;   Drug: Efavirenz
5 Recruiting Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Intervention: Drug: EVG/COBI/FTC/TDF
6 Recruiting Evaluation of the Efficacy and Safety Between Two Antiretroviral Regimens, in HIV-1-infected Treatment-naïve Subjects With Low CD4 Counts
Conditions: HIV-1 Infection;   Immunosuppression-related Infectious Disease
Interventions: Drug: DARUNAVIR;   Drug: ATAZANAVIR
7 Recruiting Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen in HIV-1/Hepatitis B Co-infected Adults
Conditions: HIV;   HBV
Intervention: Drug: E/C/F/TAF
8 Recruiting Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and Kivexa
Conditions: HIV;   Impaired Cognition
Interventions: Drug: standard care;   Drug: novel treatment
9 Unknown  A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone Maintenance
Conditions: HIV;   HIV Infections
Intervention: Drug: Raltegravir
10 Unknown  Study on the Antiviral Therapy and Immune Reconstitution of Chinese HIV/AIDS Patients
Conditions: Acquired Immune Deficiency Syndrome;   HIV Infections
Interventions: Drug: first line ARV (3TC+NVP+D4T or 3TC+NVP+AZT);   Drug: second line ARV therapy (3TC+TDF+LPV/RTV)
11 Unknown  Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment
Condition: HIV Infections
Interventions: Drug: lamivudine, abacavir , ritonavir, atazanavir;   Drug: emtricitabine, tenofovir, ritonavir, atazanavir
12 Unknown  Effect of a Non-tenofovir, Non-efavirenz-based HIV Regimen on Bone Density and Vitamin D Levels in African-American Patients With HIV Infection
Condition: HIV
Interventions: Drug: atripla;   Drug: darunavir ritonavir raltegravir
13 Recruiting Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone Homeostasis
Conditions: HIV Infection;   Osteopenia;   Osteoporosis
Intervention:
14 Unknown  Postprandial Endothelial Dysfunction After a High-Fat Meal in HIV-infected Men
Conditions: HIV Infection;   Cardiovascular Risk;   HIV Infections
Interventions: Other: Omega-3 study meal;   Other: Saturated fat study meal
15 Recruiting Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals With Herpes Simplex Virus Type 2?
Conditions: HIV Infection;   Herpesvirus 2, Human;   HIV Infections
Interventions: Drug: valacyclovir;   Drug: Placebo
16 Recruiting Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Condition: Chronic Hepatitis C Infection
Interventions: Biological: Pegylated Interferon Lambda-1a;   Drug: Daclatasvir (DCV);   Drug: Ribasphere (RBV)
17 Unknown  Effects of HIV and Hepatitis C Virus on the Brain
Conditions: HIV Infections;   Hepatitis C
Intervention:
18 Unknown  Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients
Condition: HIV Infections
Intervention: Drug: Kaletra
19 Unknown  Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients
Condition: HIV Infections
Interventions: Genetic: GX-12;   Drug: HAART
20 Unknown  Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: LPV/r;   Drug: Nucleoside Reverse Transcriptase Inhibitors;   Drug: PEG-IFNa 2a;   Drug: Ribavirin

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years